IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 37 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $525 | -89.5% | 53,578 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 53,578 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -63.6% | 53,578 | -1.1% | 0.00% | – |
| Q1 2022 | $11,000 | -62.1% | 54,178 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | -27.5% | 54,178 | -20.0% | 0.00% | – |
| Q3 2021 | $40,000 | – | 67,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 9,800 | $108,054 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |